ABIVAX Société Anonyme (LON:0RA9)
105.40
+7.10 (7.22%)
Feb 12, 2026, 5:09 PM GMT
ABIVAX Société Anonyme Revenue
ABIVAX Société Anonyme had revenue of 639.00K EUR in the quarter ending September 30, 2025, a decrease of -88.61%. This brings the company's revenue in the last twelve months to 5.31M, down -42.89% year-over-year. In the year 2024, ABIVAX Société Anonyme had annual revenue of 10.79M with 135.94% growth.
Revenue (ttm)
5.31M EUR
Revenue Growth
-42.89%
P/S Ratio
1,521.04
Revenue / Employee
79.27K EUR
Employees
67
Market Cap
7.05B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 10.79M | 6.22M | 135.94% |
| Dec 31, 2023 | 4.57M | 69.00K | 1.53% |
| Dec 31, 2022 | 4.51M | 302.00K | 7.19% |
| Dec 31, 2021 | 4.20M | 4.19M | 29,921.43% |
| Dec 31, 2020 | 14.00K | 21.00K | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| CVS Group | 673.20M |
| Genus | 672.80M |
ABIVAX Société Anonyme News
- 1 day ago - Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon. - The Motley Fool
- 13 days ago - Better Long-Term Buy: This Emerging Player or the Industry Leader? - The Motley Fool
- 13 days ago - Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance - Seeking Alpha
- 23 days ago - Eli Lilly (LLY) Denies Acquisition Talks with Abivax (ABVX) - GuruFocus
- 23 days ago - Abivax CEO responds to Lilly acquisition rumors - Seeking Alpha
- 23 days ago - Abivax CEO dismisses 'noise' around rumored Eli Lilly bid - Reuters
- 24 days ago - Prediction: This Healthcare Stock Could Soar by 72% in 2026 - The Motley Fool
- 4 weeks ago - Abivax's Options: A Look at What the Big Money is Thinking - Benzinga